MedTrace Logo

Study of Blood and Tissue Samples From Patients Receiving Androgen Deprivation for Newly Diagnosed Prostate Cancer

NCT00967954 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 120

Last updated 2014-01-10

No results posted yet for this study

Summary

RATIONALE: Studying samples of blood and tissue from patients with cancer in the laboratory may help doctors learn more about changes that occur in DNA and identify biomarkers related to cancer. It may also help doctors predict how patients will respond to treatment.

PURPOSE: This research study is looking at blood and tissue samples from patients with prostate cancer receiving androgen deprivation therapy.

Conditions

Interventions

DRUG

antiandrogen therapy

DRUG

releasing hormone agonist therapy

GENETIC

DNA analysis

GENETIC

RNA analysis

GENETIC

comparative genomic hybridization

GENETIC

gene expression analysis

OTHER

laboratory biomarker analysis

PROCEDURE

diffusion-weighted magnetic resonance imaging

PROCEDURE

magnetic resonance spectroscopic imaging

Sponsors & Collaborators

Principal Investigators

  • Vincent Gnanapragasam, MD · Cancer Research UK

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT

Eligibility

Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-09-30
Primary Completion
2013-08-31

Countries

  • United Kingdom

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00967954 on ClinicalTrials.gov